Search research articles
Contact Us
Filters
Showing results (141-150 of 153) with videos related to
Page
of 16
Sort By:
Orthopedics
|
August 1, 1991
Percutaneous computed tomography stabilization of moderate to severe slipped capital femoral epiphysis
N A Ebraheim, J J Rusin, H S An, et al.
The Science of the Total Environment
|
May 18, 2020
Geologically controlled sandy beaches: Their geomorphology, morphodynamics and classification
Shari L Gallop, David M Kennedy, Carlos Loureiro, et al.
The Journal of Bone and Joint Surgery. American Volume
|
March 1, 1988
Scapulothoracic dissociation
N A Ebraheim, H S An, W T Jackson, et al.
Journal of Medicinal Chemistry
|
May 15, 1992
Leukotriene B4 receptor antagonists: the LY255283 series of hydroxyacetophenones
D K Herron, T Goodson, N G Bollinger, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids
|
February 1, 1996
Aerosolized LTB4 produces delayed onset increases in pulmonary gas trapping
S A Silbaugh, P W Stengel, S L Cockerham, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology
|
April 14, 2000
Pharmacologic actions of the second generation leukotriene B4 receptor antagonist LY29311: in vivo pulmonary studies
S A Silbaugh, P W Stengel, S L Cockerham, et al.
Journal of Medicinal Chemistry
|
November 26, 1993
o-phenylphenols: potent and orally active leukotriene B4 receptor antagonists
M J Sofia, P Floreancig, N J Bach, et al.
Advances in Prostaglandin, Thromboxane, and Leukotriene Research
|
January 1, 1995
Prostanoid and leukotriene receptors: a progress report from the IUPHAR working parties on classification and nomenclature
R A Coleman, R M Eglen, R L Jones, et al.
Journal of Medicinal Chemistry
|
October 27, 1995
Synthetic and structure/activity studies on acid-substituted 2-arylphenols: discovery of 2-[2-propyl-3-[3-[2-ethyl-4-(4-fluorophenyl)-5- hydroxyphenoxy]-propoxy]phenoxy]benzoic acid, a high-affinity leukotriene B4 receptor antagonist
J S Sawyer, N J Bach, S R Baker, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
July 1, 1996
Recombinant human secretory phospholipase A2 released thromboxane from guinea pig bronchoalveolar lavage cells: in vitro and ex vivo evaluation of a novel secretory phospholipase A2 inhibitor
J H Fleisch, C T Armstrong, C R Roman, et al.
Page
of 16
Search research articles
Search
Showing results (141-150 of 153) with videos related to
Sort By:
Page
of 16
Orthopedics
|
August 1, 1991
Percutaneous computed tomography stabilization of moderate to severe slipped capital femoral epiphysis
N A Ebraheim, J J Rusin, H S An, et al.
The Science of the Total Environment
|
May 18, 2020
Geologically controlled sandy beaches: Their geomorphology, morphodynamics and classification
Shari L Gallop, David M Kennedy, Carlos Loureiro, et al.
The Journal of Bone and Joint Surgery. American Volume
|
March 1, 1988
Scapulothoracic dissociation
N A Ebraheim, H S An, W T Jackson, et al.
Journal of Medicinal Chemistry
|
May 15, 1992
Leukotriene B4 receptor antagonists: the LY255283 series of hydroxyacetophenones
D K Herron, T Goodson, N G Bollinger, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids
|
February 1, 1996
Aerosolized LTB4 produces delayed onset increases in pulmonary gas trapping
S A Silbaugh, P W Stengel, S L Cockerham, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology
|
April 14, 2000
Pharmacologic actions of the second generation leukotriene B4 receptor antagonist LY29311: in vivo pulmonary studies
S A Silbaugh, P W Stengel, S L Cockerham, et al.
Journal of Medicinal Chemistry
|
November 26, 1993
o-phenylphenols: potent and orally active leukotriene B4 receptor antagonists
M J Sofia, P Floreancig, N J Bach, et al.
Advances in Prostaglandin, Thromboxane, and Leukotriene Research
|
January 1, 1995
Prostanoid and leukotriene receptors: a progress report from the IUPHAR working parties on classification and nomenclature
R A Coleman, R M Eglen, R L Jones, et al.
Journal of Medicinal Chemistry
|
October 27, 1995
Synthetic and structure/activity studies on acid-substituted 2-arylphenols: discovery of 2-[2-propyl-3-[3-[2-ethyl-4-(4-fluorophenyl)-5- hydroxyphenoxy]-propoxy]phenoxy]benzoic acid, a high-affinity leukotriene B4 receptor antagonist
J S Sawyer, N J Bach, S R Baker, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
July 1, 1996
Recombinant human secretory phospholipase A2 released thromboxane from guinea pig bronchoalveolar lavage cells: in vitro and ex vivo evaluation of a novel secretory phospholipase A2 inhibitor
J H Fleisch, C T Armstrong, C R Roman, et al.
Page
of 16